NOVN.SW CHMP opinion: Thursday, September 17, 2026
Variation type II · EXJADE · Update of sections 4.3 and 4.5 of the SmPC in order to remove the existing contraindication for the combination of deferasirox with other iron chelator therapies, based on a cumulative review of the available data. The Package Leaflet is updated accordingly. The RMP vers
Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.
Every date on this page is free — forever.
A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.